Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells

Atherosclerosis

Volumn 136, Issue 2, 1998, Pages 315-324

  Kopprasch, S ^a   Leonhardt, W ^b   Pietzsch, J ^b   Kuhne H ^a  

^a Carl Gustav C   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Atherogenesis; Chemiluminescence; Hypochlorous acid; Low density lipoprotein; Oxidation; Polymorphonuclear leukocytes

Indexed keywords

APOLIPOPROTEIN B100; CATALASE; COPPER ION; CYTOCHALASIN B; HYPOCHLORITE; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; ZYMOSAN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LIPID OXIDATION; PRIORITY JOURNAL;

CELL ADHESION; CELL DEGRANULATION; CHEMILUMINESCENT MEASUREMENTS; COPPER; CYTOCHALASIN B; ENDOTHELIUM, VASCULAR; GLUCURONIDASE; HUMANS; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; LIPOPROTEINS, LDL; MURAMIDASE; NEUTROPHILS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SUPEROXIDES; UMBILICAL VEINS;

EID: 17144469680     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00233-5     Document Type: Article

References (42)

1. Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, 1992: 541-588.
2. Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8:1994;1279-1284.
3. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin Lipidol. 5:1994;422-433.
4. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., Lusis A.J. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91:1995;2488-2496.
5. Arnhold J., Wiegel D., Richter O., Hammerschmidt S., Arnold K., Krumbiegel M. Modification of low density lipoproteins by sodium hypochlorite. Biomed Biochim Acta. 50:1991;967-973.
6. Hazell L.J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J. 290:1993;165-172.
7. Hazell L.J., van den Berg J.J.M., Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem J. 302:1994;297-304.
8. Stelmaszynska T., Kukovetz E., Egger G., Schaur R.J. Possible involvement of myeloperoxidase in lipid peroxidation. Int J Biochem. 24:1992;121-128.
9. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 94:1994;437-444.
10. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed halogenation, is present in human atherosclerotic aorta [abstract]. Circulation. 94(I):1996;I2.
11. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest. 97:1996;1535-1544.
12. Kling D., Holzschuh T., Betz E. Recruitment and dynamics of leukocytes in the formation of arterial intimal thickening: a comparative study with normo- and hypercholesterolemic rabbits. Atherosclerosis. 101:1993;79-96.
13. Maeba R., Maruyama A., Tarutani O., Ueta N., Shimasaki H. Oxidized low-density lipoprotein induces the production of superoxide by neutrophils. FEBS Lett. 377:1995;309-312.
14. Leonhardt W., Pietzsch J., Nitzsche S. Very-fast ultracentrifugation of human plasma lipoproteins: influence of the centrifugal field on lipoprotein composition. Clin Chim Acta. 224:1994;21-32.
15. Morris C.J. The acid ionization constant of HOCl from 5 to 35° J Phys Chem. 70:1966;3798-3805.
16. Pietzsch J., Subat S., Nitzsche S., Leonhardt W., Schentke K.U., Hanefeld M. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition. Biochim Biophys Acta. 1254:1995;77-88.
17. Yagi K. A simple fluorimetric assay for lipoperoxide in blood plasma. Biochem Med. 15:1976;212-216.
18. Nourooz-Zadeh J., Tajaddini-Sarmadi J., Wolff A.P. Measurement of plasma hydroperoxide concentrations by ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem. 220:1994;403-409.
19. Maeba R., Shimasaki H., Ueta N. Conformational changes in oxidized LDL recognized by mouse peritoneal macrophages. Biochim Biophys Acta. 1215:1994;79-86.
20. Kopprasch S., Müller S., Köhler T., Schröder H.E. Characterization of the chemiluminescence response of polymorphonuclear leukocytes stimulated with urate crystals. J Biolumin Chemilumin. 11:1996;213-222.
21. Arnhold J., Panasenko O.M., Schiller J., Vladimirov Y.A., Arnold K. The action of hypochlorous acid on phosphatidylcholine liposomes in dependence on the content of double bonds. Stoichiometry and NMR analysis. Chem Phys Lipids. 78:1995;55-64.
22. Metcalf JA, Gallin JI, Nauseef WM, Root RK. Laboratory Manual of Neutrophil Function. New York: Raven Press, 1986: 147-148.
23. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criterion. J Clin Invest. 52:1973;2745-2756.
24. Malle E., Hazell L., Stocker R., Sattler W., Esterbauer H., Waeg G. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler Thromb Vasc Biol. 15:1995;982-989.
25. Weiss S.J., Klein R., Slivka A., Wei M. Chlorination of taurine by human neutrophils. J Clin Invest. 70:1982;598-607.
26. O'Connel A.M., Gieseg S.P., Stanlay K.K. Hypochlorite oxidation causes cross-linking of Lp(a). Biochim Biophys Acta. 1225:1995;180-186.
27. Hoff H.F., O'Neill J., Pepin J.M., Cole T.B. Macrophage uptake of cholesterol-containing particles derived from LDL and isolated from atherosclerotic lesions. Eur Heart J. 11:1990;105-115.
28. Khoo J.C., Miller E., McLoughlin P., Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 8:1988;348-358.
29. Ryu B.H., Mao F.W., Lou P., Gutman R.L., Greenspan P. Cholesteryl ester accumulation in macrophages treated with oxidized low density lipoprotein. Biosci Biotech Biochem. 59:1995;1619-1622.
30. Jessup W., Mander E.L., Dean R.T. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim Biophys Acta. 1126:1992;167-177.
31. Joris I., Zand T., Nunnari J.J., Krolikowski F.J., Majno G. Studies on the pathogenesis of atherosclerosis. I. Adhesion of mononuclear cells in the aorta of hypercholesterolemic rats. Am J Pathol. 113:1983;341-358.
32. Hahne M., Jager U., Isenmann S., Hallmann R., Vestweber D. Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J Cell Biol. 121:1993;655-664.
33. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
34. Lehr H.A., Olofsson A.M., Carew T.E., Vajkoczy P., von Andrian U.H., Hübner C., Berndt M.C., Steinberg D., Messmer K., Arfors K.E. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest. 71:1994;380-386.
35. Kume N., Cybulsky M.I., Gimbrone M.A. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 90:1992;1138-1144.
36. Lehr H.A., Frei B., Olofsson M., Carew T.E., Arfors K.E. Protection from oxidized LDL-induced leukocyte adhesion to microvascular endothelium in vivo by vitamin C but not by vitamin E. Circulation. 91:1995;1525-1532.
37. Lehr H.A., Krombach F., Münzing S., Bodlaj R., Glaubitt S.I., Seiffge D., Hübner C., von Andrian U.H., Messmer K. In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol. 146:1995;218-227.
38. Khan B.V., Parthasarathy S.S., Alexander R.W., Medford R.M. Modified low-density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest. 95:1995;1262-1270.
39. Hazen S.L., Hsu F.F., Duffin K., Heinecke J.W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J Biol Chem. 271:1996;23080-23088.
40. Weiss S.J., Test S.T., Eckman C.M., Roos D., Regiani S. Brominating oxidants generated by human eosinophils. Science. 234:1986;200-203.
41. Kotani K., Maekawa M., Kanno T., Kondo A., Toda N., Manabe M. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim Biophys Acta. 1215:1994;120-125.
42. Maggi E., Chiesa R., Melissano G., Castellano R., Astore D., Grossi A., Finardi G., Bellomo G. LDL oxidation in patients with severe carotid atherosclerosis. Arterioscler Thromb. 14:1994;1892-1899.